View Editorial Statement

Contents and Authors

The Drug Development Crisis: Efficiency and Safety, C. Thomas Caskey

Idiosyncratic Toxicity: A Convergence of Risk Factors, Roger G. Ulrich

Rethinking Electronic Health Records to Better Achieve Quality and Safety Goals, William W. Stead

Schizophrenia: New Pathological Insights and Therapies, L. Fredrik Jarskog, Seiya Miyamoto, Jeffrey A. Lieberman

Cardiac Resynchronization Treatment of Heart Failure, Ayesha Hasan, William T. Abraham

New Approaches in the Therapy of Cardiomyopathy in Muscular Dystrophy, Elizabeth M. McNally

Acute Ischemic Stroke: Overview of Recent Therapeutic Developments, Nijasri Suwanwela, Walter J. Koroshetz

Use of Stents to Treat Intracranial Cerebrovascular Disease, Philip M. Meyers, H. Christian Schumacher, Kurenai Tanji, Randall T. Higashida, Louis R. Caplan

Kidney Disease and Cardiovascular Risk, Marcello Tonelli, Marc A. Pfeffer

Cardiovascular Risks of Antiretroviral Therapies, Kristin Mondy, Pablo Tebas

Airway Surface Dehydration in Cystic Fibrosis: Pathogenesis and Therapy, Richard C. Boucher

Toward a Comprehensive Set of Asthma Susceptibility Genes, Yohan Bossé, Thomas J. Hudson

Does Anti-IgE Therapy Help in Asthma? Efficacy and Controversies, Pedro C. Avila

Advances in the Treatment of Prostate Cancer, Mark Pomerantz, Philip Kantoff

Immunotoxin Treatment of Cancer, Ira Pastan, Raffit Hassan, David J. FitzGerald, Robert J. Kreitman

NSAIDs and Cancer Prevention: Targets Downstream of COX-2, Yong I. Cha, Raymond N. DuBois

The Multiple Endocrine Neoplasia Syndromes, Vipul T. Lakhani, Y. Nancy You, Samuel A. Wells

Cancer Stem Cells: Models and Concepts, Piero Dalerba, Robert W. Cho, Michael F. Clarke

Stem Cells and Chronic Lung Disease, Brigitte N. Gomperts, Robert M. Strieter

Progress and Potential for Regenerative Medicine, Geoffrey C. Gurtner, Matthew J. Callaghan, Michael T. Longaker

The Leading Edge of Stem Cell Therapeutics, Ilyas Singec, Rahul Jandial, Andrew Crain, Guido Nikkhah, Evan Y. Snyder

New Reagents on the Horizon for Immune Tolerance, E. William St. Clair, Larry A. Turka, Andrew Saxon, Jeffrey B. Matthews, Mohamed H. Sayegh, George S. Eisenbarth, Jeffrey Bluestone

T Cell Costimulation: A Rational Target in the Therapeutic Armamentarium for Autoimmune Diseases and Transplantation, Flavio Vincenti, Michael Luggen

A Human Monoclonal Antibody Cocktail as a Novel Component of Rabies Postexposure Prophylaxis, John de Kruif, Alexander B.H. Bakker, Wilfred E. Marissen, R. Arjen Kramer, Mark Throsby, Charles E. Rupprecht, Jaap Goudsmit

Why Hasn't Eliminating Acute Rejection Improved Graft Survival?, JogiRaju Tantravahi, Karl L. Womer, Bruce Kaplan

End-Stage Renal Disease Measures of Quality, Jonathan Himmelfarb, Alan S. Kliger

Inflammatory Bowel Disease Genetics: Nod2, Judy H. Cho, Clara Abraham

New Therapeutic Approaches for Multiple Sclerosis, Philip L. De Jager, David A. Hafler

Cytokine Therapy for Crohn's Disease: Advances in Translational Research, Theresa T. Pizarro, Fabio Cominelli

Chemokine Antagonists as Therapeutics: Focus on HIV-1, Athe M.N. Tsibris, Daniel R. Kuritzkes

Current Concepts in AIDS Pathogenesis: Insights from the SIV/Macaque Model, Andrew A. Lackner, Ronald S. Veazey

Macular Degeneration, Edwin M. Stone

Targeting VEGF-A to Treat Cancer and Age-Related Macular Degeneration, Napoleone Ferrara, Robert D. Mass, Claudio Campa, Robert Kim

Purchase Information

Individuals (Worldwide)
Print & Online: $80
Order Now!

Institutions (Worldwide)
Print Only: $197
Online Only: $197
Print & Online: $236

ISSN: 0066-4129
ISBN: 978-0-8243-0558-1

View Series Home Page